Our results revealed that all three genes (SULT1E1, IGF2BP3 and MAP4K4) were all significantly overexpressed in PC tissues, suggesting that they might be potential biomarkers for PC patients (Figure 2). The gene discussed is IGF2BP3; the disease is pachyonychia congenita.